Global Endocannabinoid System Targeted Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
LPI (LP Information)' newest research report, the “Endocannabinoid System Targeted Therapeutics Industry Forecast” looks at past sales and reviews total world Endocannabinoid System Targeted Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Endocannabinoid System Targeted Therapeutics sales for 2023 through 2029. With Endocannabinoid System Targeted Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocannabinoid System Targeted Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Endocannabinoid System Targeted Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endocannabinoid System Targeted Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endocannabinoid System Targeted Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocannabinoid System Targeted Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocannabinoid System Targeted Therapeutics.
The global Endocannabinoid System Targeted Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endocannabinoid System Targeted Therapeutics players cover GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals and Therapix Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocannabinoid System Targeted Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
LPI (LP Information)' newest research report, the “Endocannabinoid System Targeted Therapeutics Industry Forecast” looks at past sales and reviews total world Endocannabinoid System Targeted Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Endocannabinoid System Targeted Therapeutics sales for 2023 through 2029. With Endocannabinoid System Targeted Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocannabinoid System Targeted Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Endocannabinoid System Targeted Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endocannabinoid System Targeted Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endocannabinoid System Targeted Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocannabinoid System Targeted Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocannabinoid System Targeted Therapeutics.
The global Endocannabinoid System Targeted Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endocannabinoid System Targeted Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endocannabinoid System Targeted Therapeutics players cover GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals and Therapix Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocannabinoid System Targeted Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Inhalation
- Others
- Autoimmune Disorders
- Genetic Disorders
- Neurological Disorders
- Pain Disorders
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GW Pharmaceuticals
- MAKScientific
- Corbus Pharmaceuticals
- Tilray
- Pure Green
- Avicanna
- GB Sciences
- Botanix Pharmaceuticals
- Therapix Biosciences
- Zelira Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size 2018-2029
2.1.2 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endocannabinoid System Targeted Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Inhalation
2.2.3 Others
2.3 Endocannabinoid System Targeted Therapeutics Market Size by Type
2.3.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Endocannabinoid System Targeted Therapeutics Segment by Application
2.4.1 Autoimmune Disorders
2.4.2 Genetic Disorders
2.4.3 Neurological Disorders
2.4.4 Pain Disorders
2.5 Endocannabinoid System Targeted Therapeutics Market Size by Application
2.5.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Endocannabinoid System Targeted Therapeutics Market Size Market Share by Players
3.1.1 Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS BY REGIONS
4.1 Endocannabinoid System Targeted Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.3 APAC Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.4 Europe Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
5.2 Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
5.3 Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023)
6.2 APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
6.3 APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endocannabinoid System Targeted Therapeutics by Country (2018-2023)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST
10.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Endocannabinoid System Targeted Therapeutics Forecast
10.1.3 APAC Endocannabinoid System Targeted Therapeutics Forecast
10.1.4 Europe Endocannabinoid System Targeted Therapeutics Forecast
10.1.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast
10.2 Americas Endocannabinoid System Targeted Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.2 Canada Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.3 Mexico Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.4 Brazil Endocannabinoid System Targeted Therapeutics Market Forecast
10.3 APAC Endocannabinoid System Targeted Therapeutics Forecast by Region (2024-2029)
10.3.1 China Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.2 Japan Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.3 Korea Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.4 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.5 India Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.6 Australia Endocannabinoid System Targeted Therapeutics Market Forecast
10.4 Europe Endocannabinoid System Targeted Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.2 France Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.3 UK Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.4 Italy Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.5 Russia Endocannabinoid System Targeted Therapeutics Market Forecast
10.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.2 South Africa Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.3 Israel Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.4 Turkey Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.5 GCC Countries Endocannabinoid System Targeted Therapeutics Market Forecast
10.6 Global Endocannabinoid System Targeted Therapeutics Forecast by Type (2024-2029)
10.7 Global Endocannabinoid System Targeted Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Information
11.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GW Pharmaceuticals Main Business Overview
11.1.5 GW Pharmaceuticals Latest Developments
11.2 MAKScientific
11.2.1 MAKScientific Company Information
11.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 MAKScientific Main Business Overview
11.2.5 MAKScientific Latest Developments
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Information
11.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Corbus Pharmaceuticals Main Business Overview
11.3.5 Corbus Pharmaceuticals Latest Developments
11.4 Tilray
11.4.1 Tilray Company Information
11.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Offered
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Tilray Main Business Overview
11.4.5 Tilray Latest Developments
11.5 Pure Green
11.5.1 Pure Green Company Information
11.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Offered
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pure Green Main Business Overview
11.5.5 Pure Green Latest Developments
11.6 Avicanna
11.6.1 Avicanna Company Information
11.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Offered
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Avicanna Main Business Overview
11.6.5 Avicanna Latest Developments
11.7 GB Sciences
11.7.1 GB Sciences Company Information
11.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GB Sciences Main Business Overview
11.7.5 GB Sciences Latest Developments
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Information
11.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Botanix Pharmaceuticals Main Business Overview
11.8.5 Botanix Pharmaceuticals Latest Developments
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Information
11.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Therapix Biosciences Main Business Overview
11.9.5 Therapix Biosciences Latest Developments
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Information
11.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Zelira Therapeutics Main Business Overview
11.10.5 Zelira Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size 2018-2029
2.1.2 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endocannabinoid System Targeted Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Inhalation
2.2.3 Others
2.3 Endocannabinoid System Targeted Therapeutics Market Size by Type
2.3.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Endocannabinoid System Targeted Therapeutics Segment by Application
2.4.1 Autoimmune Disorders
2.4.2 Genetic Disorders
2.4.3 Neurological Disorders
2.4.4 Pain Disorders
2.5 Endocannabinoid System Targeted Therapeutics Market Size by Application
2.5.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Endocannabinoid System Targeted Therapeutics Market Size Market Share by Players
3.1.1 Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS BY REGIONS
4.1 Endocannabinoid System Targeted Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.3 APAC Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.4 Europe Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
5.2 Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
5.3 Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023)
6.2 APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
6.3 APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endocannabinoid System Targeted Therapeutics by Country (2018-2023)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST
10.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Endocannabinoid System Targeted Therapeutics Forecast
10.1.3 APAC Endocannabinoid System Targeted Therapeutics Forecast
10.1.4 Europe Endocannabinoid System Targeted Therapeutics Forecast
10.1.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast
10.2 Americas Endocannabinoid System Targeted Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.2 Canada Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.3 Mexico Endocannabinoid System Targeted Therapeutics Market Forecast
10.2.4 Brazil Endocannabinoid System Targeted Therapeutics Market Forecast
10.3 APAC Endocannabinoid System Targeted Therapeutics Forecast by Region (2024-2029)
10.3.1 China Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.2 Japan Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.3 Korea Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.4 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.5 India Endocannabinoid System Targeted Therapeutics Market Forecast
10.3.6 Australia Endocannabinoid System Targeted Therapeutics Market Forecast
10.4 Europe Endocannabinoid System Targeted Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.2 France Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.3 UK Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.4 Italy Endocannabinoid System Targeted Therapeutics Market Forecast
10.4.5 Russia Endocannabinoid System Targeted Therapeutics Market Forecast
10.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.2 South Africa Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.3 Israel Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.4 Turkey Endocannabinoid System Targeted Therapeutics Market Forecast
10.5.5 GCC Countries Endocannabinoid System Targeted Therapeutics Market Forecast
10.6 Global Endocannabinoid System Targeted Therapeutics Forecast by Type (2024-2029)
10.7 Global Endocannabinoid System Targeted Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Information
11.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GW Pharmaceuticals Main Business Overview
11.1.5 GW Pharmaceuticals Latest Developments
11.2 MAKScientific
11.2.1 MAKScientific Company Information
11.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 MAKScientific Main Business Overview
11.2.5 MAKScientific Latest Developments
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Information
11.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Corbus Pharmaceuticals Main Business Overview
11.3.5 Corbus Pharmaceuticals Latest Developments
11.4 Tilray
11.4.1 Tilray Company Information
11.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Offered
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Tilray Main Business Overview
11.4.5 Tilray Latest Developments
11.5 Pure Green
11.5.1 Pure Green Company Information
11.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Offered
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pure Green Main Business Overview
11.5.5 Pure Green Latest Developments
11.6 Avicanna
11.6.1 Avicanna Company Information
11.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Offered
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Avicanna Main Business Overview
11.6.5 Avicanna Latest Developments
11.7 GB Sciences
11.7.1 GB Sciences Company Information
11.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GB Sciences Main Business Overview
11.7.5 GB Sciences Latest Developments
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Information
11.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Botanix Pharmaceuticals Main Business Overview
11.8.5 Botanix Pharmaceuticals Latest Developments
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Information
11.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Therapix Biosciences Main Business Overview
11.9.5 Therapix Biosciences Latest Developments
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Information
11.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Zelira Therapeutics Main Business Overview
11.10.5 Zelira Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Inhalation
Table 4. Major Players of Others
Table 5. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered
Table 14. Endocannabinoid System Targeted Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Endocannabinoid System Targeted Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Endocannabinoid System Targeted Therapeutics
Table 46. Key Market Challenges & Risks of Endocannabinoid System Targeted Therapeutics
Table 47. Key Industry Trends of Endocannabinoid System Targeted Therapeutics
Table 48. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GW Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 53. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 54. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GW Pharmaceuticals Main Business
Table 56. GW Pharmaceuticals Latest Developments
Table 57. MAKScientific Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 58. MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered
Table 59. MAKScientific Main Business
Table 60. MAKScientific Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. MAKScientific Latest Developments
Table 62. Corbus Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 63. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 64. Corbus Pharmaceuticals Main Business
Table 65. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Corbus Pharmaceuticals Latest Developments
Table 67. Tilray Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 68. Tilray Endocannabinoid System Targeted Therapeutics Product Offered
Table 69. Tilray Main Business
Table 70. Tilray Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Tilray Latest Developments
Table 72. Pure Green Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 73. Pure Green Endocannabinoid System Targeted Therapeutics Product Offered
Table 74. Pure Green Main Business
Table 75. Pure Green Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Pure Green Latest Developments
Table 77. Avicanna Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 78. Avicanna Endocannabinoid System Targeted Therapeutics Product Offered
Table 79. Avicanna Main Business
Table 80. Avicanna Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Avicanna Latest Developments
Table 82. GB Sciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 83. GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered
Table 84. GB Sciences Main Business
Table 85. GB Sciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. GB Sciences Latest Developments
Table 87. Botanix Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 88. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 89. Botanix Pharmaceuticals Main Business
Table 90. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Botanix Pharmaceuticals Latest Developments
Table 92. Therapix Biosciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 93. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered
Table 94. Therapix Biosciences Main Business
Table 95. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Therapix Biosciences Latest Developments
Table 97. Zelira Therapeutics Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 98. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered
Table 99. Zelira Therapeutics Main Business
Table 100. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Zelira Therapeutics Latest Developments
Table 1. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Inhalation
Table 4. Major Players of Others
Table 5. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered
Table 14. Endocannabinoid System Targeted Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Endocannabinoid System Targeted Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Endocannabinoid System Targeted Therapeutics
Table 46. Key Market Challenges & Risks of Endocannabinoid System Targeted Therapeutics
Table 47. Key Industry Trends of Endocannabinoid System Targeted Therapeutics
Table 48. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GW Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 53. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 54. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GW Pharmaceuticals Main Business
Table 56. GW Pharmaceuticals Latest Developments
Table 57. MAKScientific Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 58. MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered
Table 59. MAKScientific Main Business
Table 60. MAKScientific Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. MAKScientific Latest Developments
Table 62. Corbus Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 63. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 64. Corbus Pharmaceuticals Main Business
Table 65. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Corbus Pharmaceuticals Latest Developments
Table 67. Tilray Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 68. Tilray Endocannabinoid System Targeted Therapeutics Product Offered
Table 69. Tilray Main Business
Table 70. Tilray Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Tilray Latest Developments
Table 72. Pure Green Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 73. Pure Green Endocannabinoid System Targeted Therapeutics Product Offered
Table 74. Pure Green Main Business
Table 75. Pure Green Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Pure Green Latest Developments
Table 77. Avicanna Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 78. Avicanna Endocannabinoid System Targeted Therapeutics Product Offered
Table 79. Avicanna Main Business
Table 80. Avicanna Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Avicanna Latest Developments
Table 82. GB Sciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 83. GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered
Table 84. GB Sciences Main Business
Table 85. GB Sciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. GB Sciences Latest Developments
Table 87. Botanix Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 88. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered
Table 89. Botanix Pharmaceuticals Main Business
Table 90. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Botanix Pharmaceuticals Latest Developments
Table 92. Therapix Biosciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 93. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered
Table 94. Therapix Biosciences Main Business
Table 95. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Therapix Biosciences Latest Developments
Table 97. Zelira Therapeutics Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors
Table 98. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered
Table 99. Zelira Therapeutics Main Business
Table 100. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Zelira Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endocannabinoid System Targeted Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endocannabinoid System Targeted Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Endocannabinoid System Targeted Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2022
Figure 10. Endocannabinoid System Targeted Therapeutics in Autoimmune Disorders
Figure 11. Global Endocannabinoid System Targeted Therapeutics Market: Autoimmune Disorders (2018-2023) & ($ Millions)
Figure 12. Endocannabinoid System Targeted Therapeutics in Genetic Disorders
Figure 13. Global Endocannabinoid System Targeted Therapeutics Market: Genetic Disorders (2018-2023) & ($ Millions)
Figure 14. Endocannabinoid System Targeted Therapeutics in Neurological Disorders
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 16. Endocannabinoid System Targeted Therapeutics in Pain Disorders
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market: Pain Disorders (2018-2023) & ($ Millions)
Figure 18. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2022
Figure 19. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player in 2022
Figure 20. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. APAC Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Europe Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 25. Americas Endocannabinoid System Targeted Therapeutics Value Market Share by Country in 2022
Figure 26. United States Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2022
Figure 31. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2022
Figure 32. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2022
Figure 33. China Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2022
Figure 40. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Figure 41. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Figure 42. Germany Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. APAC Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Europe Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. United States Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Canada Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. China Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Japan Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Korea Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. India Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Australia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Germany Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. France Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. UK Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Italy Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Russia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Spain Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. Israel Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 80. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endocannabinoid System Targeted Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endocannabinoid System Targeted Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Endocannabinoid System Targeted Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2022
Figure 10. Endocannabinoid System Targeted Therapeutics in Autoimmune Disorders
Figure 11. Global Endocannabinoid System Targeted Therapeutics Market: Autoimmune Disorders (2018-2023) & ($ Millions)
Figure 12. Endocannabinoid System Targeted Therapeutics in Genetic Disorders
Figure 13. Global Endocannabinoid System Targeted Therapeutics Market: Genetic Disorders (2018-2023) & ($ Millions)
Figure 14. Endocannabinoid System Targeted Therapeutics in Neurological Disorders
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 16. Endocannabinoid System Targeted Therapeutics in Pain Disorders
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market: Pain Disorders (2018-2023) & ($ Millions)
Figure 18. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2022
Figure 19. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player in 2022
Figure 20. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. APAC Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Europe Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2018-2023 ($ Millions)
Figure 25. Americas Endocannabinoid System Targeted Therapeutics Value Market Share by Country in 2022
Figure 26. United States Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2022
Figure 31. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2022
Figure 32. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2022
Figure 33. China Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2022
Figure 40. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Figure 41. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Figure 42. Germany Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Endocannabinoid System Targeted Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. APAC Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Europe Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. United States Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Canada Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. China Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Japan Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Korea Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. India Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Australia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Germany Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. France Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. UK Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Italy Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Russia Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Spain Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. Israel Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Endocannabinoid System Targeted Therapeutics Market Size 2024-2029 ($ Millions)
Figure 80. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Application (2024-2029)
